Recall: D-0550-2023

Class II - Potentially Harmful

Class IIClassification

2023-03-16Initiated

OngoingStatus

Northwind Pharmaceuticals LLCFirm

Product

Doxazosin Tablets, USP, 4mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-109-52

Reason

CGMP Deviations

Distribution

Nationwide with the United States

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.